A carregar...

Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease

The N-methyl-d-aspartate receptor antagonist, memantine, is licensed for the treatment of moderate to severe Alzheimer’s disease (AD). Memantine is administered both as a monotherapy and as an add-on therapy in patients already receiving acetylcholinesterase inhibitors. Several meta-analyses have be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rive, Benoît, Gauthier, Serge, Costello, Sophie, Marre, Caroline, François, Clément
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709077/
https://ncbi.nlm.nih.gov/pubmed/23765561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0074-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!